A study to evaluate the effect of hepatic insufficiency on the pharmacokinetics (PK) of ACP-196

Trial Identifier: ACE-HI-001
Sponsor: Acerta Pharma BV
NCTID:: NCT04867941
Start Date: October 2014
Primary Completion Date: February 2015

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, Florida Miami, Florida, United States, 33136
United States, Florida Orlando, Florida, United States, 32809
United States, Tennessee Knoxville, Tennessee, United States, 37920